CA
NZ
UK
AU
IND
US
Boost Run (NASDAQ:BRUN) shares rose 13.08% in pre-market trading to $25.50, up from a prior close of $22.55, ahead of the company's second quarter fiscal 2026 earnings report, due before market open today with a conference call scheduled for 8:00 a.m. Eastern Time. Analysts …
Globant (NYSE:GLOB) shares fell 11.69% in pre-market trading to $36.20, down from a prior close of $40.99, after the digital transformation company missed adjustedEarningsestimates and lowered its full-year 2026 revenue guidance. AdjustedEarnings Per Shareof $1.40 missed the $1.49 estimate by 6.04%, while revenue of …
Lexaria Bioscience (NASDAQ:LEXX) shares are pulling back modestly in pre-market trading, giving back a small piece of Thursday's sharp 32.35% rally that followed the announcement of a new partnership. The Kelowna, Canada-based company is a drug delivery innovator known for its patented DehydraTECH technology, …
MapLight Therapeutics (NASDAQ:MPLT) shares are climbing in pre-market trading after the clinical-stage biopharmaceutical company reported positive Phase 2 results and provided aBusinessupdate alongside its second-quarter earnings. MapLight is a Redwood City, California-based company focused on developing circuit-specific therapies for central nervous system disorders including …
Valneva SE (NASDAQ:VALN) shares are surging in pre-market trading after theEuropean Medicines Agency (EMA)validated the Marketing Authorization Application (MAA) for PF-07307405, the company's 6-valent outer surface protein A (OspA)-based Lyme disease vaccine candidate developed inPartnershipwith Pfizer. Validation means the EMA has accepted the application …
Zentalis Pharmaceuticals (NASDAQ:ZNTL) shares are trading lower in pre-market trading after the clinical-stage oncology company announced the pricing of a dilutive share offering. The San Diego-based company is a clinical oncology innovator advancing late-stage development of azenosertib, an investigational, potentially first-in-class WEE1 inhibitor being …
If you're watching Zoetis (NYSE:ZTS), the stock is essentially holding steady in pre-market trading as the market weighs a new positive regulatory catalyst against broader concerns about softening U.S. companion-animal demand. The FDA has authorized Simparica Trio, already the first product approved to provide …
Eton Pharmaceuticals (NASDAQ:ETON) shares are surging in pre-market trading, up roughly 23% to around $50, after the company reportedBlowoutsecond-quarter 2026 results driven by the HEMANGEOL relaunch and broad rare-disease portfolio growth. Revenue nearly doubled year-over-year to $37.6 million, topping the $27.1 million consensus, while …
Boston Scientific (NYSE:BSX) shares are climbing in pre-market trading, building on a recovery that began after a sharp selloff earlier this year triggered by a cut to full-year 2026 organic growth guidance. The rally is being reinforced by notable insider buying: CEO Michael F. …
President Donald Trump signed a proclamation imposing tariffs on imports of drones and their components, including from several key US allies, citing excessive American reliance on foreign drone suppliers. The proclamation sets a 100% ad valorem tariff on drones weighing more than 25 kilograms …
Please wait processing your request...